Brad Kahl, MD

Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology Director, Lymphoma Program, Washington University School of Medicine

Clinical Expertise

Hematologic malignancies, lymphoma, chronic lymphocytic leukemia

Research Interest

My interests involve clinical and translational efforts to improve outcomes for lymphoma patients. I am particularly interested in novel agents and testing of those agents in clinical trials. I have led several clinical trials in the Eastern Cooperative Oncology Group and currently serve as Chair of the ECOG Lymphoma Committee.

Education

1994: MD, Tufts University School of Medicine, Boston

Training

1994 - 1998: Resident, internal medicine, University of Wisconsin, Madison
1998 - 2000: Fellow, hematology, University of Wisconsin, Madison

Board Certification

1997: American Board of Internal Medicine
2001, 2011: American Board of Internal Medicine - Hematology

Selected Research Publications

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts.

Martin P, Cohen JB, Wang M, [...] Kahl B, [...] Salles G
J Clin Oncol 2023

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.

Rutherford SC, Yin J, Pederson L, [...] Kahl B, [...] Leonard JP
J Clin Oncol 2023

Top advances in lymphoma for 2021.

Patel DA, Kahl BS
Cancer 2022

Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001.

Stephens DM, Li H, Constine LS, [...] Kahl BS, [...] Friedberg JW
Haematologica 2022

CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL).

Kahl BS, Giannopoulos K, Jurczak W, [...] Tam CS
Clin Lymphoma Myeloma Leuk 2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Campo E, Jaffe ES, Cook JR, [...] Kahl BS, [...] Zelenetz AD
Blood 2022

Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP.

Hill BT, Kahl B
Expert Rev Hematol 2022

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.

Tam CS, Brown JR, Kahl BS, [...] Hillmen P
Lancet Oncol 2022

Current Treatments in Marginal Zone Lymphoma.

Alderuccio JP, Kahl BS
Oncology (Williston Park, NY) 2022

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.

Casulo C, Larson MC, Lunde JJ, [...] Kahl BS, [...] Maurer MJ
Lancet Haematol 2022

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Spira A, Zhou X, Chen L, [...] Kahl B
Clin Lymphoma Myeloma Leuk 2022

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

Orellana-Noia VM, Reed DR, McCook AA, [...] Kahl BS, [...] Portell CA
Blood 2022

Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study.

Diefenbach C, Kahl BS, McMillan A, [...] Abrisqueta P
Lancet Haematol 2021

Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.

Karmali R, Switchenko JM, Goyal S, [...] Kahl BS, [...] Cohen JB
Am J Hematol 2021

Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma.

Foltz JA, Hess BT, Bachanova V, [...] Kahl B, [...] Fehniger TA
Clin Cancer Res 2021

View All Publications

Contact Information

Washington University Medical Campus

4921 Parkview Place
Saint Louis, MO 63110
South St. Louis County

5225 Midamerica Plaza
St. Louis, MO 63129

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment